financetom
Business
financetom
/
Business
/
CIBC Up 0.85% In US Premarket On Q2 Adjusted Earnings and Revenues Beat
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
CIBC Up 0.85% In US Premarket On Q2 Adjusted Earnings and Revenues Beat
May 29, 2025 3:47 AM

06:24 AM EDT, 05/29/2025 (MT Newswires) -- Canadian Imperial Bank of Commerce ( CM ) was at last look up 0.85% in US premarket trade after it reported fiscal Q2 adjusted earnings Thursday of C$2.05 per diluted share, up from $1.75 a year earlier. Analysts polled by FactSet expected $1.88.

Revenue for the quarter ended April 30 was $7.02 billion, up from $6.16 billion a year earlier. Analysts surveyed by FactSet expected $6.95 billion.

CIBC closed down $0.56 at $93.99 on the TSX yesterday, but remained near 52 week highs.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Paycom Software Insider Sold Shares Worth $699,151, According to a Recent SEC Filing
Paycom Software Insider Sold Shares Worth $699,151, According to a Recent SEC Filing
May 22, 2024
05:01 PM EDT, 05/22/2024 (MT Newswires) -- Chad R. Richison, 10% Owner, Director, Co-CEO, President and Chairman, on May 21, 2024, sold 3,900 shares in Paycom Software ( PAYC ) for $699,151. Following the Form 4 filing with the SEC, Richison has control over a total of 6,772,341 shares of the company, with 3,088,058 shares held directly and 3,684,283 controlled...
Cytokinetics, Royalty Pharma Unveil up to $575 Million Funding to Advance Research Pipeline
Cytokinetics, Royalty Pharma Unveil up to $575 Million Funding to Advance Research Pipeline
May 22, 2024
05:00 PM EDT, 05/22/2024 (MT Newswires) -- Cytokinetics ( CYTK ) disclosed a collaboration late Wednesday under which Royalty Pharma ( RPRX ) will provide capital totaling up to $575 million to support the commercialization of aficamten and advance its expanding cardiovascular pipeline. The aim here is also to diversify access to capital as the company advances its muscle biology-directed...
GlobalFoundries Launches $950 Million Secondary Public Stock Offering; Shares Fall After Hours
GlobalFoundries Launches $950 Million Secondary Public Stock Offering; Shares Fall After Hours
May 22, 2024
05:03 PM EDT, 05/22/2024 (MT Newswires) -- GlobalFoundries ( GFS ) said Wednesday it launched a $950 million secondary public offering of ordinary shares. Mubadala Technology Investment is the selling shareholder and plans to give underwriters a 30-day option to buy up to $112.5 million in additional shares, GlobalFoundries ( GFS ) said. GlobalFoundries ( GFS ) isn't selling any...
--Zoetis Keeps Quarterly Dividend at $0.432 a Share, Payable Sept. 4 to Shareholders of Record July 18
--Zoetis Keeps Quarterly Dividend at $0.432 a Share, Payable Sept. 4 to Shareholders of Record July 18
May 22, 2024
05:01 PM EDT, 05/22/2024 (MT Newswires) -- Price: 171.00, Change: -1.05, Percent Change: -0.61 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved